VEGFR-2 Kinase Domain Inhibition As a Scaffold for Anti-angiogenesis: Validation of the Anti-angiogenic Effects of Carotenoids from in DMBA Model of Breast Carcinoma in Wistar Rats

Overview

Journal Toxicol Rep

Date 2021 Aug 19

PMID 34408968

Citations 7

Authors

Damilohun Samuel Metibemu

Oluseyi Adeboye Akinloye

Adio Jamiu Akamo

Jude Ogechukwu Okoye

David Ajiboye Ojo

Eric Morifi

Idowu Olaposi Omotuyi

Affiliations

Soon will be listed here.

Abstract

Vascular endothelial growth factor (VEGF) and its receptor-2 (VEGFR-2) mediated tumorigenesis, metastasis, and angiogenesis are the cause of the increased levels of mortality associated with breast cancer and other forms of cancer. Inhibition of VEGF and VEGFR-2 provides a great therapeutic option in the management of cancer. This study employed VEGFR-2 kinase domain inhibition as an anti-angiogenic scaffold and further validate the anti-angiogenic effects of the lead phytochemicals, carotenoids from in 7, 12-Dimethylbenz[a]anthracene (DMBA) model of breast carcinoma in Wistar rats. Phytochemicals characterized from 6 reported anti-cancer plants were screened against the VEGFR-2 kinase domain. The lead phytochemicals, carotenoids from were isolated and subjected to Liquid Chromatography-Electrospray Ionization-Mass Spectrometry (LC-ESI-MS) for characterization. The anti-angiogenic potentials of the carotenoid isolates were validated in the DMBA model of breast carcinoma in female Wistar rats through assessment of the expression of anti-angiogenic related mRNAs, histopathological analysis, and molecular docking. Treatment with carotenoid isolates (100 mg/kg and 200 mg/kg) significantly (p < 0.05) downregulated the expression of VEGF, VEGFR, Epidermal Growth Factor Receptor Hypoxia-Inducible Factor-1(), and Matrix Metalloproteinase-2 ) mRNAs in the mammary tumours, while the expression of Chromodomain Helicase DNA-Binding Protein-1 (CHD-1) mRNA was significantly (p < 0.05) upregulated. DMBA induced comedo and invasive ductal subtypes of breast carcinoma. The binding of astaxanthin, 7,7',8,8'-tetrahydro-β,β-carotene, and beta-carotene-15,15'-epoxide to the ATP binding site led to the DFG-out conformation with binding energies of -8.2 kcal/mol, -10.3 kcal/mol, and -10.5 kcal/mol respectively. Carotenoid isolates demonstrated anti-angiogenic and anti-proliferating potentials via VEGFR-2 kinase domain inhibition.

Citing Articles

Health Benefits of High Voltage Electrostatic Field Processing of Fruits and Vegetables.

Valdez-Miranda J, Guitierrez-Lopez G, Robles-de la Torre R, Hernandez-Sanchez H, Robles-Lopez M Plant Foods Hum Nutr. 2024; 79(2):260-269.

PMID: 38761282 DOI: 10.1007/s11130-024-01190-x.

Catechin from Anonna senegalensis is a Potential Inhibitor of Erectile Dysfunction: Implication for Its Use in Male Sexual Enhancement.

Folawiyo M, Omotuyi I, Ajao F, Besong E, Adelusi T, Ajayi A Appl Biochem Biotechnol. 2023; 195(8):4936-4964.

PMID: 37115384 DOI: 10.1007/s12010-023-04557-z.

Anti-microbial, anti-oxidant, and anti-breast cancer properties unraveled in yeast carotenoids produced cost-effective fermentation technique utilizing waste hydrolysate.

Sinha S, Das S, Saha B, Paul D, Basu B Front Microbiol. 2023; 13:1088477.

PMID: 36741891 PMC: 9889640. DOI: 10.3389/fmicb.2022.1088477.

Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases.

Metibemu D, Ogungbe I Molecules. 2022; 27(18).

PMID: 36144741 PMC: 9503763. DOI: 10.3390/molecules27186005.

The Antiangiogenic Activity of Flaxseed Oil Alone and Combination with Mefenamic Acid in Vivo and in Vitro Assay.

Al-Zubaidy N, Sahib H Asian Pac J Cancer Prev. 2022; 23(5):1711-1717.

PMID: 35633556 PMC: 9587884. DOI: 10.31557/APJCP.2022.23.5.1711.

References

Zhao X, Deng X, Park K, Qiu L, Pang L . Purple bamboo salt has anticancer activity in TCA8113 cells in vitro and preventive effects on buccal mucosa cancer in mice in vivo. Exp Ther Med. 2013; 5(2):549-554. PMC: 3570125. DOI: 10.3892/etm.2012.848. View

Enyedy I, Egan W . Can we use docking and scoring for hit-to-lead optimization?. J Comput Aided Mol Des. 2008; 22(3-4):161-8. DOI: 10.1007/s10822-007-9165-4. View

Baselga J . Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist. 2002; 7 Suppl 4:2-8. DOI: 10.1634/theoncologist.7-suppl_4-2. View

Oguro Y, Miyamoto N, Okada K, Takagi T, Iwata H, Awazu Y . Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorg Med Chem. 2010; 18(20):7260-73. DOI: 10.1016/j.bmc.2010.08.017. View

Wishart D, Djoumbou Feunang Y, Marcu A, Guo A, Liang K, Vazquez-Fresno R . HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2017; 46(D1):D608-D617. PMC: 5753273. DOI: 10.1093/nar/gkx1089. View

Chew B, Park J, Wong M, Wong T . A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res. 1999; 19(3A):1849-53. View

Metibemu D, Akinloye O, Akamo A, Okoye J, Ojo D, Morifi E . Carotenoid isolates of Spondias mombin demonstrate anticancer effects in DMBA-induced breast cancer in Wistar rats through X-linked inhibitor of apoptosis protein (XIAP) antagonism and anti-inflammation. J Food Biochem. 2020; 44(12):e13523. DOI: 10.1111/jfbc.13523. View

Lu K, Bhat M, Basu S . Plants and their active compounds: natural molecules to target angiogenesis. Angiogenesis. 2016; 19(3):287-95. PMC: 4930694. DOI: 10.1007/s10456-016-9512-y. View

Lian L, Li X, Xu M, Li X, Wu M, Zhang Y . VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Cancer. 2019; 19(1):183. PMC: 6393973. DOI: 10.1186/s12885-019-5322-0. View

10.

Sliwoski G, Kothiwale S, Meiler J, Lowe Jr E . Computational methods in drug discovery. Pharmacol Rev. 2014; 66(1):334-95. PMC: 3880464. DOI: 10.1124/pr.112.007336. View

11.

Linnewiel-Hermoni K, Khanin M, Danilenko M, Zango G, Amosi Y, Levy J . The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity. Arch Biochem Biophys. 2015; 572:28-35. DOI: 10.1016/j.abb.2015.02.018. View

12.

Pradeep C, Sunila E, Kuttan G . Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther. 2005; 4(4):315-21. DOI: 10.1177/1534735405282557. View

13.

Faul F, Erdfelder E, Buchner A, Lang A . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41(4):1149-60. DOI: 10.3758/BRM.41.4.1149. View

14.

Li W, Li V, Hutnik M, Chiou A . Tumor angiogenesis as a target for dietary cancer prevention. J Oncol. 2011; 2012:879623. PMC: 3184418. DOI: 10.1155/2012/879623. View

15.

Xie Y, Li J, Shen K, Meng F, Wang L, Han G . [Effect of HIF-1α on Angiogenesis-Related Factors in K562 Cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019; 27(5):1476-1481. DOI: 10.19746/j.cnki.issn.1009-2137.2019.05.019. View

16.

Ryden L, Linderholm B, Nielsen N, Emdin S, Jonsson P, Landberg G . Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer. Breast Cancer Res Treat. 2004; 82(3):147-54. DOI: 10.1023/B:BREA.0000004357.92232.cb. View

17.

Shekhar M, Tait L, Pauley R, Wu G, Santner S, Nangia-Makker P . Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biol Ther. 2008; 7(11):1774-82. PMC: 4657570. DOI: 10.4161/cbt.7.11.6781. View

18.

Costa C, Soares R, Reis-Filho J, Leitao D, Amendoeira I, Schmitt F . Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol. 2002; 55(6):429-34. PMC: 1769664. DOI: 10.1136/jcp.55.6.429. View

19.

Wu Z, Zeng R, Su Y, Gu M, Huang S . Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy. Head Neck. 2012; 35(5):689-94. DOI: 10.1002/hed.23010. View

20.

Zwartsen A, Chottanapund S, Kittakoop P, Navasumrit P, Ruchirawat M, van Duursen M . Evaluation of anti-tumour properties of two depsidones - Unguinol and Aspergillusidone D - in triple-negative MDA-MB-231 breast tumour cells. Toxicol Rep. 2019; 6:1216-1222. PMC: 6880138. DOI: 10.1016/j.toxrep.2019.10.012. View